DocSym
β
Searchsearch
Search
(C39.9) Malignant neoplasm: ill-defined sites within the respiratory system
More details coming soon
149 045 in individuals diagnosis malignant neoplasm: ill-defined sites within the respiratory system confirmed
21 657 deaths with diagnosis malignant neoplasm: ill-defined sites within the respiratory system
15% mortality rate associated with the disease malignant neoplasm: ill-defined sites within the respiratory system
Diagnosis malignant neoplasm: ill-defined sites within the respiratory system is diagnosed Men are 33.84% more likely than Women
99 741
Men receive the diagnosis malignant neoplasm: ill-defined sites within the respiratory system
13 124 (13.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
49 304
Women receive the diagnosis malignant neoplasm: ill-defined sites within the respiratory system
8 533 (17.3 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm: ill-defined sites within the respiratory system - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-5, 10-19, 25-94
Less common in men the disease occurs at Age 0-1, 5-9, 20-24, 95+Less common in women the disease occurs at Age 0-9, 20-24
In Women diagnosis is most often set at age 10-19, 25-95+
Disease Features malignant neoplasm: ill-defined sites within the respiratory system
Absence or low individual and public risk
Malignant neoplasm: ill-defined sites within the respiratory system - what does this mean
Malignant neoplasms, also known as cancer, occur when cells in the respiratory system grow and divide uncontrollably. these cells form tumors that can spread to other parts of the body, often compromising the function of the affected organs. malignant neoplasms can occur in ill-defined sites within the respiratory system, such as the lungs, trachea, bronchi, and larynx, and can cause symptoms such as shortness of breath, chest pain, and coughing up blood.
What happens during the disease - malignant neoplasm: ill-defined sites within the respiratory system
Malignant neoplasm is a type of cancer that is characterized by the uncontrolled growth of abnormal cells in the respiratory system. this is caused by genetic mutations that cause the cells to divide uncontrollably, leading to the formation of a tumor. this tumor can cause damage to the surrounding tissue and can spread to other parts of the body. the exact cause of this mutation is unknown, but it is believed to be linked to environmental factors, such as exposure to certain chemicals or radiation.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Imaging studies, such as X-rays, CT scans, and MRI scans
- Endoscopic examinations, such as bronchoscopy, laryngoscopy, and esophagoscopy
- Tissue sampling, such as biopsy and cytology
- Blood tests
- Pulmonary function tests
- Thoracentesis
- Bronchoalveolar lavage
- Thoracoscopy
Treatment and Medical Assistance
Main goal of the Treatment: To reduce the size of the malignant neoplasm and prevent its spread.
- Administering chemotherapy
- Performing radiation therapy
- Undergoing surgery to remove the tumor
- Receiving targeted therapy to target specific genetic changes within the cancer cells
- Participating in clinical trials to test new treatments
- Undergoing immunotherapy to boost the immune system's ability to fight the cancer
- Receiving hormone therapy to reduce the amount of hormones that can stimulate the growth of cancer cells
19 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm: ill-defined sites within the respiratory system - Prevention
The best way to prevent malignant neoplasms in the respiratory system is to reduce exposure to environmental carcinogens such as tobacco smoke, air pollution, and asbestos, as well as to practice healthy lifestyle habits such as eating a balanced diet, exercising regularly, and avoiding alcohol and drug use. additionally, regular medical check-ups and screenings can help detect any early signs of the disease.